Searchable abstracts of presentations at key conferences in endocrinology

ea0074ncc55 | Highlighted Cases | SFENCC2021

A case of adrenocortical carcinoma in a female with rapid virilisation and mild Cushing’s Syndrome

Lam George , Ahmed Fahad

Section 1: Case history An 86 year old female presented to hospital after being found on the floor and had profound lower limb oedema. She was treated for a urinary tract infection and possible heart failure. On examination she had significant hirsutism and bruised skin. She had a past medical history of BCC removal and primary hyperparathyroidism. Her ECOG performance status was 1–2. There was a family history of pancreatic cancer (father) and pancreatic neuroendocrine tumour...

ea0037ep286 | Calcium and Vitamin D metabolism | ECE2015

Thalassemia-induced osteoporosis and bisphosphonate treatment: a systematic review and meta-analysis

Tsartsalis Athanasios , Lambrou George , Savvidis Christos , Chrousos George , Kattamis Antonis

Introduction: Osteopenia and osteoporosis develop with aging in thalassemia patients despite clinical treatment therapy has improved. Bisphosphonates, which are potent inhibitors of osteoclastic bone resorption, have been recently used to correct the bone abnormality in thalassemia with encouraging results. Bisphosphonates are a class of drugs that prevent the loss of bone mass, used to treat osteoporosis and similar diseases. They are the most commonly prescribed drugs used t...

ea0022p347 | Diabetes | ECE2010

Quantitative and qualitative changes in T regulatory lymphocytes (Tregs) in newly-diagnosed patients with type 1 diabetes

Paschou Stavroula , Vartholomatos George , Kolaitis Nikolaos , Papadopoulos George , Tsatsoulis Agathocles

Introduction: T regulatory lymphocytes (Tregs) are defined as CD4+CD25high T lymphocytes and are thought to regulate immune tolerance. The Foxp3 protein level in Tregs is proportional to CD25 protein surface expression and regulatory function, but inversely proportional to IL-7R (CD127) level, the receptor for the growth and survival of T cells. We investigated possible differences in Tregs between newly diagnosed type 1 diabetes (DM1) patients and contro...

ea0014p313 | (1) | ECE2007

Fas and FasL expression on peripheral lymphocytes in patients with autoimmune thyroid disease

Fountoulakis Stelios , Vartholomatis George , Philippou George , Tsatsoulis Agathocles

Objective: The Fas/Fas ligand (FasL) apoptotic pathway is activated in patients with autoimmune thyroid disease (AITD). It is believed that Fas and FasL expression in intrathyroidal T lymphocytes and thyrocytes is regulated in a manner resulting in thyroid cell apoptosis in Hashimoto’s thyroiditis (HT) or lymphocyte apoptosis in Graves’ disease (GD). The hypothesis that Fas and FasL may be differentially expressed on peripheral lymphocytes in patients with HT and GD ...

ea0014p492 | (1) | ECE2007

The challenge of managing thionamide induced agranulocytosis in a patient with Graves’ disease

Iqbal Nosheen , Dissanayake A , Thomson George

We report a 44 year old lady with a history of weight loss, anxiety and ‘prominent eyes’. She was clinically and biochemically thyrotoxic (FT4: 158.1 pmol/L [12–22], FT3:56.5 pmol/L [2.8–7.], TSH:<0.08 mU/L [0.30–4.30]). She was commenced on carbimazole and propranolol. Failure to attend regular clinic appointments or comply with drug therapy over the next few years resulted in huge swings of her thyroid status from severe thyrotoxicosis to profoun...

ea0013p57 | Clinical practice/governance and case reports | SFEBES2007

Malignancy associated hypercalcemia with elevated levels of parathormone

George Ajith , Oriolowo A , Flanagan Daniel

A 56 year old lady presented with a short history of neuromuscular weakness. She was dehydrated but conscious, alert and oriented and without focal neurology. Her initial blood results revealed a corrected calcium 5.02 mmol/L, phosphate 1.49 mmol/L, alkaline phosphatase 152 iu/L, urea 31.8 mmol/L and creatinine 266 micromol/L.Intravenous rehydration with normal saline and 90 mg of pamidronate was given. She received 4 litres of normal saline daily and her renal functions norma...

ea0041ep545 | Diabetes therapy | ECE2016

Long-term effects of Stevia rebaduiana on glucose and lipid profile, adipocytokines, markers of inflammation and oxidation status in patients with metabolic syndrome

Kassi Eva , Landis George , Pavlaki Aikaterini , Lambrou George , Mantzou Aimilia , Androulakis Ioannis , Giannakou Andreas , Papanikolaou Eleni , Chrousos George

Introduction: Metabolic syndrome (MetS) is a cluster of interconnected factors that directly increase the risk of DM2 and CVD. Stevia rebaudiana (a low calorie natural sweetener) and its compounds are known for anti-hyperglycemic, anti-inflammatory, anti-oxidant, anti-hypertensive effects.Methods: Thirty-eight patients (age 47.3±10.3 years) (nmales=14, nfemales=24) with MetS (NCEP/ATPIII criteria) wer...

ea0077op1.4 | Thyroid | SFEBES2021

Autoimmune thyrotoxicosis: Is first line treatment with anti-thyroid medication good enough?

Pooley George , Shishkin Bronwyn , DeSilva Akila

Introduction: Autoimmune thyrotoxicosis (AT) affects 2-5% of the Western population. Despite current NICE guidelines recommending radioiodine as first-line treatment for AT, practical considerations such as licensing often prevent this. Typically, anti-thyroid medication (carbimazole or propylthiouracil) is initially offered. Patients are usually counselled that the remission rate following a 12-18 month course of anti-thyroid medication is approximately 50%.<p class="abst...

ea0077p157 | Bone and Calcium | SFEBES2021

A case of familial hyperparathyroidism with an uncommon mutation

Quader Monzoor , Buch Harit , George Arun

A 29 year-old nursing student, was incidentally detected to have high serum calcium 3.43 mmol/l (2.2-2.6) whilst being treated for community acquired pneumonia. She had no symptoms of hypercalcaemia. Her uncle had been operated for primary hyperparathyroidism (PHPT) although only limited details were available. PTH of 28 pmol/l (1.6-7.2) confirmed the diagnosis of PHPT. She had vitamin D deficiency, normal liver and renal function. She was offered parathyroidectomy and preoper...

ea0055p38 | Poster Presentations | SFEEU2018

A case of pheochromocytoma with SDHA mutation

Millar Lucy , George Angela , Morganstein Daniel

A 58-year-old gentleman who was otherwise well presented with urinary symptoms. As part of his investigation for this he underwent a CT scan which showed an incidental 6 cm right adrenal mass compressing the inferior vena cava and superior pole of the right kidney with a 6-mm pulmonary nodule. He was subsequently found to have a raised urinary normetanephrine of 48.81 (normal range 0–3.3) suggestive that the mass was a pheochromocytoma. Retrospectively he reported episode...